Top Buy
| Wertpapier | Buy | Sell | Buy (1M) | Sell (1M) | Kurs | Kursziel | Potential |
|---|---|---|---|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. | 17 | 1 | 3 | 0 | 37,40 € | 84,74 € | 126,59 % |
| Esperion Therapeutis.Inc. | 15 | 0 | 3 | 0 | 2,31 € | 8,55 € | 269,94 % |
| Halozyme Therapeutics Inc. | 15 | 0 | 3 | 0 | 41,73 € | 47,17 € | 13,04 % |
| G1 Therapeutics | 16 | 1 | 3 | 0 | 4,25 € | 10,05 € | 136,45 % |
| Rhythm Pharmaceuticals | 15 | 0 | 2 | 0 | 35,00 € | 45,98 € | 31,37 % |
| Akero Therapeutics Inc | 14 | 0 | 2 | 0 | 18,56 € | 38,19 € | 105,78 % |
| Stoke Therapeutics Inc | 15 | 1 | 2 | 0 | 14,10 € | 21,00 € | 48,96 % |
| Repligen Corp. | 13 | 0 | 1 | 0 | 153,75 € | 184,76 € | 20,17 % |
| Prothena Corp. plc | 13 | 0 | 1 | 0 | 21,60 € | 80,10 € | 270,83 % |
| Intellia Therapeutics Inc | 13 | 1 | 1 | 1 | 24,44 € | 60,55 € | 147,77 % |
| Geron Corp. | 12 | 0 | 2 | 0 | 3,41 € | 4,63 € | 35,53 % |
| MacroGenics Inc. | 12 | 0 | 4 | 0 | 3,91 € | 12,99 € | 232,28 % |
| Arrowhead Pharmaceuticals Inc. | 14 | 2 | 2 | 0 | 23,06 € | 52,03 € | 125,61 % |
| Catalyst Pharmaceutical Partners Inc | 11 | 0 | 1 | 0 | 15,23 € | 24,13 € | 58,46 % |
| Corcept Therapeutics Inc. | 11 | 0 | 3 | 0 | 26,89 € | 35,43 € | 31,76 % |
| Celldex Therapeutics | 11 | 1 | 2 | 0 | 35,20 € | 56,62 € | 60,84 % |
| Heron Therapeutics Inc. | 11 | 1 | 4 | 0 | 3,22 € | 4,59 € | 42,52 % |
| Charles River Labs Intl | 10 | 0 | 1 | 0 | 204,40 € | 248,57 € | 21,61 % |
| Chromadex Corp | 11 | 1 | 1 | 0 | 3,04 € | 5,58 € | 83,41 % |
| Gilead Sciences Inc | 11 | 1 | 3 | 0 | 62,40 € | 84,81 € | 35,92 % |
| Rigel Pharmaceutical Inc. | 10 | 0 | 1 | 0 | 0,88 € | 13,77 € | 1462,45 % |
| Evolus Inc | 10 | 0 | 4 | 0 | 11,90 € | 20,46 € | 71,95 % |
| Incyte Corp. | 12 | 2 | 3 | 0 | 53,00 € | 78,42 € | 47,97 % |
| Verastem Inc. | 10 | 0 | 1 | 0 | 11,20 € | 24,63 € | 119,95 % |
| Xencor Inc. | 10 | 1 | 1 | 0 | 21,40 € | 32,58 € | 52,24 % |